{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:31:22Z","timestamp":1793395882625,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T00:00:00Z","timestamp":1653696000000},"content-version":"vor","delay-in-days":147,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004169","name":"Meiji Seika Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004169","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.toxrep.2022.05.020","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T12:38:30Z","timestamp":1654173510000},"page":"1255-1260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Neurotoxicity associated with colistin methanesulfonate treatment is enhanced by concomitant sevoflurane inhalation"],"prefix":"10.1016","volume":"9","author":[{"given":"Mai","family":"Gotoda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Enoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shino","family":"Shishido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxrep.2022.05.020_bib1","unstructured":"Centers for Disease Control and Prevention, Biggest Threats & Data, (2021). https:\/\/www.cdc.gov\/drugresistance\/biggest-threats.html (Accessed February 21, 2021)."},{"key":"10.1016\/j.toxrep.2022.05.020_bib2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1473-3099(06)70580-1","article-title":"Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections","volume":"6","author":"Li","year":"2006","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.toxrep.2022.05.020_bib3","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/514732","article-title":"Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii","volume":"28","author":"Levin","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.toxrep.2022.05.020_bib4","doi-asserted-by":"crossref","first-page":"923","DOI":"10.5694\/j.1326-5377.1970.tb63262.x","article-title":"Acute renal failure due to overdosage of colistin","volume":"2","author":"Brown","year":"1970","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.toxrep.2022.05.020_bib5","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1080\/22221751.2020.1754133","article-title":"Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019)","volume":"9","author":"El-Sayed Ahmed","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.toxrep.2022.05.020_bib6","doi-asserted-by":"crossref","DOI":"10.1186\/cc3995","article-title":"Toxicity of polymyxins: a systematic review of the evidence from old and recent studies","volume":"10","author":"Falagas","year":"2006","journal-title":"Crit. Care"},{"issue":"2014","key":"10.1016\/j.toxrep.2022.05.020_bib7","article-title":"Colistin-mediated neurotoxicity","author":"Wadia","year":"2014","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.toxrep.2022.05.020_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2147\/IJNRD.S42791","article-title":"Acute respiratory muscle weakness and apnea in a critically ill patient induced by colistin neurotoxicity: key potential role of hemoadsorption elimination during continuous venovenous hemofiltration","volume":"6","author":"Honore","year":"2013","journal-title":"Int. J. Nephrol. Renov. Dis."},{"key":"10.1016\/j.toxrep.2022.05.020_bib9","article-title":"Respiratory Muscle Paralysis Associated With Colistin, Polymyxin B, and Muscle Relaxants Drugs: A Case Report","volume":"4","author":"Myint","year":"2016","journal-title":"J. Investig. Med. High. Impact Case Rep."},{"key":"10.1016\/j.toxrep.2022.05.020_bib10","unstructured":"GlaxoSmithKline plc, ALDREB for Injection. Package Insert., London, UK. (2017). https:\/\/pins.japic.or.jp\/pdf\/newPINS\/00065435.pdf (Accessed February 20, 2022)."},{"key":"10.1016\/j.toxrep.2022.05.020_bib11","first-page":"417","article-title":"The interaction of neuromuscular blocking effects with sevoflurane and new muscle relaxants in rats","volume":"29","author":"Fukushima","year":"2001","journal-title":"St. Marian. Med. J."},{"key":"10.1016\/j.toxrep.2022.05.020_bib12","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/jac\/dkq183","article-title":"Dose-ranging pharmacokinetics of colistin methanesulphonate (CMS) and colistin in rats following single intravenous CMS doses","volume":"65","author":"Marchand","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.toxrep.2022.05.020_bib13","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/jac\/dkh167","article-title":"Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate","volume":"53","author":"Li","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.toxrep.2022.05.020_bib14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/omcr\/omab080","article-title":"Colistin neurotoxicity mimicking Guillain-Barr\u00e9 syndrome in a patient with cystic fibrosis: case report and review","volume":"2021","author":"Camargo","year":"2021","journal-title":"Oxf. Med. Case Rep."},{"key":"10.1016\/j.toxrep.2022.05.020_bib15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1213\/00000539-200208000-00022","article-title":"Characterization of the interactions between volatile anesthetics and neuromuscular blockers at the muscle nicotinic acetylcholine receptor","volume":"95","author":"Paul","year":"2002","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.toxrep.2022.05.020_bib16","article-title":"ALDREB for injection","author":"GlaxoSmithKline plc","year":"2019","journal-title":"Interview Form."},{"key":"10.1016\/j.toxrep.2022.05.020_bib17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/clpt.2011.48","article-title":"Pharmacokinetics of colistin and colistimethate sodium after a single 80-mg intravenous dose of CMS in young healthy volunteers","volume":"89","author":"Couet","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.toxrep.2022.05.020_bib18","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.toxrep.2022.05.020_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24030653","article-title":"Molecular mechanisms of colistin-induced nephrotoxicity","volume":"24","author":"Gai","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.toxrep.2022.05.020_bib20","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/00000542-200605000-00025","article-title":"Impact of hypothermia on the response to neuromuscular blocking drugs","volume":"104","author":"Heier","year":"2006","journal-title":"Anesthesiology"}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750022001342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750022001342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:49:49Z","timestamp":1793393389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750022001342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":20,"alternative-id":["S2214750022001342"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2022.05.020","relation":{},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurotoxicity associated with colistin methanesulfonate treatment is enhanced by concomitant sevoflurane inhalation","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2022.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}